Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 3-002: Difference between revisions

From GxPlex

Jump to: navigation, search
imported>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
Β 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
|has_document=Document:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
|RefScope=IVD
|module=6
|RefDocPart=Annex XIV
|unit=6.3.1
|scope=IVD
|doc_part=Annex XIV
Chapter II
Chapter II
SectionΒ  3
SectionΒ  3
|RefLanguage=EN
|language=EN
|RefTags=TAG-00271-Ret-Arc ++ TAG-00343-Doc-ten ++ TAG-00231-Per-ung ++ TAG-00017-Spo-die ++ TAG-00073-Arc-arc
|entry_by=Florian Adragna
|RefModule=6
|contributors=
|RefUnit=6.3.1
|tags=TAG-00271-Ret-Arc ++ TAG-00343-Doc-ten ++ TAG-00231-Per-ung ++ TAG-00017-Spo-die ++ TAG-00073-Arc-arc
}}
|tags_display=[[Glossary:TAG-00271-Ret-Arc|Sponsor record retention]], [[Glossary:TAG-00343-Doc-ten|Documentation]], [[Glossary:TAG-00231-Per-ung|Performance study]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00073-Arc-arc|Archiving]]
Β 
|comment=Repeated entry: 4.2.5 ++ 6.3.1
{{:Document:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023}}
Β 
{| class="wikitable gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 6 β€” Unit 6.3.1
|-
! Scope
| IVD
|-
! Document part
| Annex XIV
Chapter II
SectionΒ  3
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags
| [[Glossary:TAG-00271-Ret-Arc|Sponsor record retention]], [[Glossary:TAG-00343-Doc-ten|Documentation]], [[Glossary:TAG-00231-Per-ung|Performance study]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00073-Arc-arc|Archiving]]
|-
! Comment
| Repeated entry: 4.2.5 ++ 6.3.1


Sponsor documentation retention (performance study, repeated)
Sponsor documentation retention (performance study, repeated)
|}
|content=OTHER OBLIGATIONS OF THE SPONSOR
Β 
== Content ==
OTHER OBLIGATIONS OF THE SPONSOR


3. The documentation mentioned in this Annex shall be kept for a period of time of at least 10 years after the clinical performance study with the device in question has ended, or, in the event that the device is subsequently placed on the market, for at least 10 years after the last device has been placed on the market.
3. The documentation mentioned in this Annex shall be kept for a period of time of at least 10 years after the clinical performance study with the device in question has ended, or, in the event that the device is subsequently placed on the market, for at least 10 years after the last device has been placed on the market.


Each Member State shall require that the documentation referred to in this Annex is kept at the disposal of the competent authorities for the period indicated in the first subparagraph in case the sponsor, or his contact person, established within its territory, goes bankrupt or ceases its activity prior to the end of this period.
Each Member State shall require that the documentation referred to in this Annex is kept at the disposal of the competent authorities for the period indicated in the first subparagraph in case the sponsor, or his contact person, established within its territory, goes bankrupt or ceases its activity prior to the end of this period.
}}

Latest revision as of 13:50, 16 July 2026



Document information
Reference EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023
Validity area EU
Scope(s) IVD
Document name Regulation (EU) 2017/746 - in vitro diagnostic medical devices
Version / Revision 20-Mar-2023
Status Current
Document type Legal act
Language(s) EN
Description Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 6 β€” Unit 6.3.1
Scope IVD
Document part Annex XIV

Chapter II Section 3

Language EN
Original entry by Florian Adragna
Contributors
Tags Sponsor record retention, Documentation, Performance study, Sponsor, Archiving

Content

OTHER OBLIGATIONS OF THE SPONSOR

3. The documentation mentioned in this Annex shall be kept for a period of time of at least 10 years after the clinical performance study with the device in question has ended, or, in the event that the device is subsequently placed on the market, for at least 10 years after the last device has been placed on the market.

Each Member State shall require that the documentation referred to in this Annex is kept at the disposal of the competent authorities for the period indicated in the first subparagraph in case the sponsor, or his contact person, established within its territory, goes bankrupt or ceases its activity prior to the end of this period.